| Katelyn Minor, | |
|
169 Ice Blue Rd, Bozeman, MT 59718-9422 | |
| (252) 202-0078 | |
| Not Available |
| Full Name | Katelyn Minor |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 169 Ice Blue Rd, Bozeman, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366061806 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP-SP-LIC-8776 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katelyn Minor, 169 Ice Blue Rd, Bozeman, MT 59718-9422 Ph: (252) 202-0078 | Katelyn Minor, 169 Ice Blue Rd, Bozeman, MT 59718-9422 Ph: (252) 202-0078 |
News Archive
Children who undergo brief periods of intense exercise may exhibit lung dysfunction or other symptoms similar to those experienced by asthma patients, even when no history of asthma exists, according to a study conducted by researchers at the University of California's Irvine and Miller Children's Hospital.
Findings from the Rotterdam study show how the trajectories of people's blood pressure in mid to late life have varying effects on their risk of having a stroke or dying.
Micromet, Inc. today announced the presentation of updated results from a Phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with minimal residual disease (MRD) positive acute lymphoblastic leukemia (ALL). An analysis of long-term efficacy data demonstrated that blinatumomab produced prolonged remissions in patients with ALL. As of November 2010, the hematologic disease free survival (DFS) was 60%, with a follow-up of up to 27.5 months.
Critical Diagnostics, the exclusive developer of the Presage® ST2 Assay, announces the publication of the Penn Heart Failure Study (PHFS) in an advance e-publication of the January 19, 2010 edition of Circulation: Heart Failure. The results of this study demonstrated that ST2 levels not only predict outcomes for ambulatory outpatients with chronic heart failure, they more effectively risk-stratify such patients.
› Verified 7 days ago
Amanda Martin, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4840 Alpha Dr, Bozeman, MT 59718 Phone: 406-209-2554 | |
Neuro Rehab Associates, Inc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2135 Charlotte St Ste 3, Bozeman, MT 59718 Phone: 406-586-8030 Fax: 406-586-8036 | |
Mrs. Jessie Elizabeth Sabo Lee, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 320 N Church Ave, Bozeman, MT 59715 Phone: 406-579-7394 Fax: 406-282-8094 | |
Allegra Rose Bereszniewicz, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2075 Charlotte St Ste 1, Bozeman, MT 59718 Phone: 406-556-9853 Fax: 406-219-3223 | |
Foundation Therapy Services Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Edelweiss Dr Ste 7, Bozeman, MT 59718 Phone: 406-581-8440 | |
Cathy Fisher, M.S., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2135 Charlotte St, Suite 3, Bozeman, MT 59718 Phone: 406-586-8030 | |
Lucy Bikulcs, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2417 Par Ct, Bozeman, MT 59715 Phone: 435-491-0059 |